Contract 75N91020F00003
Leidos Biomedical Research Inc · Department Of Health And Human Services · September 27, 2020
Leidos Biomedical Research Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 27, 2020 for $975.24 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Frederick, MD. This is a task or delivery order issued under parent IDIQ 75N91019D00024. The contract has been modified 12 times since the base award It uses cost-plus contract pricing. The most recent modification was on June 18, 2026. If all options are exercised, the contract could reach $1.78 billion.
Contract details
- PIID
- 75N91020F00003
- Parent IDIQ
- 75N91019D00024
- Award type
- Delivery Order
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full And Open Competition
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- Operation Of Government-Owned Contractor-Operated (Goco) R&D Facilities
- Place of performance
- Frederick, MD
- First action
- September 27, 2020
- Latest action
- June 18, 2026
Description
FY26 UDO INITIATIVE - NCI OPERATIONAL TASK ORDER FY20 - FY23
Modification timeline
-
June 18, 2026Mod P00045 · Funding Only Action$1.78B
-
June 26, 2025Mod P00001 · Supplemental Agreement For Work Within ScopeANALYSIS FOR NSC 726188 (3 LOTS): APPEARANCE, PROTON NMR, INFRARED, HPLC* (ASSAY, IMPURITY), MOISTURE (KF). POP IS 05/01/2020 - 09/30/2020$37.7K
-
September 6, 2024Mod P00044 · Funding Only ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.78B
-
August 31, 2024Mod P00043 · Other Administrative ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.78B
-
August 27, 2024Mod P00042 · Funding Only ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.75B
-
August 13, 2024Mod P00041 · Funding Only ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.71B
-
July 19, 2024Mod P00040 · Other Administrative ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.72B
-
June 26, 2024Mod P00039 · Other Administrative ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.72B
-
September 28, 2023Mod P00032 · Funding Only ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.62B
-
September 28, 2022Mod P00022 · Funding Only ActionTHE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE…$1.17B
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $77.58M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $8.41M |
| Technical Resources International, Inc. | Department Of Health And Human Services | July 2, 2026 | $39.32M |
| Consolidated Safety Services Incorporated | Department Of Health And Human Services | July 2, 2026 | $465.3K |
| University Of Mississippi Medical Center | Department Of Health And Human Services | July 2, 2026 | $0 |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | July 2, 2026 | $10.12M |
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $2.75B |
| 2 | California Institute Of Technology | 240 | $979.40M |
| 3 | The Johns Hopkins University Applied Physics Laboratory Llc | 204 | $482.74M |
| 4 | Lockheed Martin Corporation | 4 | $461.91M |
| 5 | Lockheed Martin Corp | 9 | $317.27M |
| 6 | The Aerospace Corporation | 85 | $308.18M |
| 7 | Fermi Forward Discovery Group, Llc | 1 | $289.92M |
| 8 | Lockheed Martin Corp | 7 | $285.45M |
| 9 | Amentum Technology, Inc. | 4 | $253.24M |
| 10 | The Mitre Corporation | 50 | $222.51M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91020F00003?
Contract 75N91020F00003 is a federal contract awarded to Leidos Biomedical Research Inc by Department Of Health And Human Services on September 27, 2020 for $975.24 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 12 times since the base award.
Who won contract 75N91020F00003?
Leidos Biomedical Research Inc won contract 75N91020F00003 from Department Of Health And Human Services.
How much is contract 75N91020F00003 worth?
Contract 75N91020F00003 has obligated $975.24 million to date, with a total potential value of $1.78 billion if all options are exercised.